BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30374243)

  • 1. Endovascular Stenting in 2 Patients with Benign Superior Vena Cava Syndrome.
    Hooker JB; Hawkins BM; Abu-Fadel MS
    Tex Heart Inst J; 2018 Aug; 45(4):264-269. PubMed ID: 30374243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
    Breault S; Doenz F; Jouannic AM; Qanadli SD
    Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interventional treatment of the acute and subacute vena cava superior syndrome].
    Kühn JP; Mensel B; Ewert R; Bollmann T
    Pneumologie; 2013 Oct; 67(10):573-9. PubMed ID: 23999695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular stenting for occluded superior vena cava in an infant with short bowel syndrome.
    Harada T; Inoue M; Uchida K; Ohashi H; Kusunoki M
    Pediatr Int; 2020 Feb; 62(2):244-246. PubMed ID: 32053857
    [No Abstract]   [Full Text] [Related]  

  • 5. Endovascular Treatment of Superior Vena Cava Syndrome via Balloon-in-Balloon Catheter Technique with a Palmaz Stent.
    Shatila W; Almanfi A; Massumi M; Dougherty KG; Parekh DR; Strickman NE
    Tex Heart Inst J; 2016 Dec; 43(6):520-523. PubMed ID: 28100973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.
    Kalra M; Gloviczki P; Andrews JC; Cherry KJ; Bower TC; Panneton JM; Bjarnason H; Noel AA; Schleck C; Harmsen WS; Canton LG; Pairolero PC
    J Vasc Surg; 2003 Aug; 38(2):215-23. PubMed ID: 12891100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior vena cava syndrome: role of the interventionalist.
    Rachapalli V; Boucher LM
    Can Assoc Radiol J; 2014 May; 65(2):168-76. PubMed ID: 23415716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign superior vena cava syndrome: stenting is now the first line of treatment.
    Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
    J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
    Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
    Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
    Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
    Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
    [No Abstract]   [Full Text] [Related]  

  • 11. Endovascular stenting of nonmalignant superior vena cava syndrome.
    Sheikh MA; Fernandez BB; Gray BH; Graham LM; Carman TL
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):405-11. PubMed ID: 15945106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular Treatment of Bilateral Pulmonary Artery Stenoses and Superior Vena Cava Syndrome in a Patient with Advanced Mediastinal Fibrosis.
    Valentin LI; Kuban JD; Ramanathan R; Whigham CJ
    Tex Heart Inst J; 2016 Jun; 43(3):249-51. PubMed ID: 27303243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.
    Nguyen NP; Borok TL; Welsh J; Vinh-Hung V
    Thorax; 2009 Feb; 64(2):174-8. PubMed ID: 19176843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular management of inferior vena cava filter thrombotic occlusion.
    Branco BC; Montero-Baker MF; Espinoza E; Gamero M; Zea-Vera R; Labropoulos N; Leon LR
    Vascular; 2018 Oct; 26(5):483-489. PubMed ID: 29498327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
    Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
    Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Open and Endovascular Treatment of Superior Vena Cava Syndrome of Benign Aetiology.
    Sfyroeras GS; Antonopoulos CN; Mantas G; Moulakakis KG; Kakisis JD; Brountzos E; Lattimer CR; Geroulakos G
    Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):238-254. PubMed ID: 28007450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular stenting for treatment of superior vena cava syndrome.
    Karaca O; Akçakoyun M; Esen O; Esen AM
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):414-6. PubMed ID: 20019457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
    Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
    Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular Stenting in Superior Vena Cava Syndrome: A Systematic Review and Meta-analysis.
    Aung EY; Khan M; Williams N; Raja U; Hamady M
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1236-1254. PubMed ID: 35821122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
    Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
    Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.